Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chelsea Mayoh

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
JCO Precision Oncology|September 11, 2020
Crizotinib and Surgery for Long-Term Disease Control in Children and Adolescents With ALK-Positive Inflammatory Myofibroblastic TumorsToby Trahair, Andrew J Gifford, Ashleigh Fordham, et al.
NPJ Precision Oncology|February 13, 2021
Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumorSumanth Nagabushan, Loretta M S Lau, Paulette Barahona, et al.
Cancer Research|July 12, 2020
Suppression of ABCE1-Mediated mRNA Translation Limits N-MYC-Driven Cancer ProgressionJixuan Gao, MoonSun Jung, Chelsea Mayoh, et al.
Cancers|March 29, 2023
Inhibitors of the Oncogenic PA2G4-MYCN Protein-Protein InterfaceHassina Massudi, Jie-Si Luo, Jessica K Holien, et al.
International Journal of Cancer|July 21, 2019
Potent antileukemic activity of curaxin CBL0137 against MLL-rearranged leukemiaKlaartje Somers, Angelika Kosciolek, Angelika Bongers, et al.
Nature Communications|February 13, 2021
Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomasAaminah Khan, Laura D Gamble, Dannielle H Upton, et al.
Cancer Research|August 21, 2020
Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune EvasionFlorida Voli, Emanuele Valli, Luigi Lerra, et al.
Cancer Research|April 4, 2018
Network Modeling of microRNA-mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCNChi Yan Ooi, Daniel R Carter, Bing Liu, et al.
British Journal of Cancer|January 11, 2020
Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapyAlvin Kamili, Andrew J Gifford, Nancy Li, et al.
NPJ Precision Oncology|May 10, 2025
A novel TRKB-activating internal tandem duplication characterizes a new mechanism of receptor tyrosine kinase activationLauren M Brown, Gabor Tax, Pablo Acera Mateos, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
JCO Precision Oncology|September 11, 2020
Crizotinib and Surgery for Long-Term Disease Control in Children and Adolescents With ALK-Positive Inflammatory Myofibroblastic TumorsToby Trahair, Andrew J Gifford, Ashleigh Fordham, et al.
NPJ Precision Oncology|February 13, 2021
Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumorSumanth Nagabushan, Loretta M S Lau, Paulette Barahona, et al.
Cancer Research|July 12, 2020
Suppression of ABCE1-Mediated mRNA Translation Limits N-MYC-Driven Cancer ProgressionJixuan Gao, MoonSun Jung, Chelsea Mayoh, et al.
Cancers|March 29, 2023
Inhibitors of the Oncogenic PA2G4-MYCN Protein-Protein InterfaceHassina Massudi, Jie-Si Luo, Jessica K Holien, et al.
International Journal of Cancer|July 21, 2019
Potent antileukemic activity of curaxin CBL0137 against MLL-rearranged leukemiaKlaartje Somers, Angelika Kosciolek, Angelika Bongers, et al.
Nature Communications|February 13, 2021
Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomasAaminah Khan, Laura D Gamble, Dannielle H Upton, et al.
Cancer Research|August 21, 2020
Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune EvasionFlorida Voli, Emanuele Valli, Luigi Lerra, et al.
Cancer Research|April 4, 2018
Network Modeling of microRNA-mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCNChi Yan Ooi, Daniel R Carter, Bing Liu, et al.
British Journal of Cancer|January 11, 2020
Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapyAlvin Kamili, Andrew J Gifford, Nancy Li, et al.
NPJ Precision Oncology|May 10, 2025
A novel TRKB-activating internal tandem duplication characterizes a new mechanism of receptor tyrosine kinase activationLauren M Brown, Gabor Tax, Pablo Acera Mateos, et al.
Pageof 10